XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.87

-0.2%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (10737)	7/12/1999 2:28:00 AM
From: aknahow	Read Replies (1) of 17367

Interested in buying a call on something that might help in the fight against antibiotic resistance? From Allegans part of the press release. <<<<<<"A number of pathogenic bacterial strains are showing increased resistance to currently available antibiotics, creating growing concern among the medical community. Allergan intends to address this need by developing products that make use of rBPI's synergy with antibiotics, including potential use against resistant strains of bacteria.">>>>>>>> They bought a call on just use for the eye. Is antibiotic resistance an exciting important story on its' own, without reference to sepsis? Does Mycoprex reprsent a call on the success of a fungicide? If the above is correct then XOMA is more than a call on just the Meningoccemia trial results.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next